Xiaman Wang

BGI Group (China) — China

Medicine · Health Sciences

8h-index416citations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(5), Acute Myeloid Leukemia Research(4), Hematopoietic Stem Cell Transplantation(3), Erythrocyte Function and Pathophysiology(3), DNA Repair Mechanisms(2)

Publications17 total

Self-sampled specimens demonstrate comparable accuracy and consistency to clinician-sampled specimens for HPV detection among men who have sex with men in China
Sexually Transmitted Infections·2022· 9 cited
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2
Leukemia·2022· 34 citedOpen Access
Genetic characteristics of human papillomavirus type 16, 18, 52 and 58 in southern China
Genomics·2021· 10 citedOpen Access
Combined liver–cytokine humanization comes to the rescue of circulating human red blood cells
Science·2021· 34 citedOpen Access
Reconstruction of Sickle Cell Disease with Circulating Sickling Red Blood Cells in Novel Humanized Cytokines and Liver Mistrg Mice
Blood·2020· 3 cited
m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development
Immunity·2020· 174 citedOpen Access
IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition
Life Sciences·2020· 44 cited
PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors
Blood·2019· 5 cited
U2AF1 Driver Mutations in Hematopoietic Disorders Alter but Do Not Abrogate RNA Binding and Enlighten Structural Dependencies of the U2AF-RNA Complex
Blood·2019· 1 cited
Loss of METTL3 Mediated m6A RNA Modification Results in Double-Stranded RNA Induced Innate Immune Response and Hematopoietic Failure
Blood·2019· 1 cited
In Vivo reconstruction of Human Erythropoiesis with Circulating Mature Human RBCs in Humanized Liver Mistrg Mice
Blood·2019
Insulin-like Growth Factor-1-Induced Epithelial-Mesenchymal Transition Promotes Multiple Myeloma Progression
Blood·2019
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Nature Communications·2019· 79 citedOpen Access
Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens
Hematology·2019· 4 citedOpen Access
A Highly Efficient and Faithful MDS Patient-Derived Xenotransplantation Model for Pre-Clinical Studies
2018· 18 citedOpen Access
Serum Peptidome Based Multiple Myeloma Renal Impairment Biomarker Screening
Blood·2015
Serum Platelet Factor 4 Is a Promising Therapeutic Response and Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
Blood·2014

Frequent Co-authors

Toma Tebaldi(10), Stephanie Halene(10), Yimeng Gao(9), Yuanbin Song(9), Rana Gbyli(9), Xiaoying Fu(9), Richard A. Flavell(9), Giulia Biancon(8), Wei Liu(5), Amisha Patel(5), Ashley Qin(5), Anastasia Ardasheva(4), Mina L. Xu(4), Emanuela M. Bruscia(4), Ying Shen(4), Padmavathi Mamillapalli(4), Aili He(4), Poorval Joshi(3), Gabriella Viero(3), Ashley Taylor(3)